NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Ardelyx Inc (NASDAQ: ARDX)

 
ARDX Technical Analysis
5
As on 18th May 2022 ARDX Share Price closed @ 0.66 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.27 & Strong Sell for SHORT-TERM with Stoploss of 6.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ARDX Share Price

Open 0.68 Change Price %
High 0.68 1 Day -0.03 -4.35
Low 0.66 1 Week -0.06 -8.33
Close 0.66 1 Month -0.41 -38.32
Volume 1650569 1 Year -5.44 -89.18
52 Week High 8.98 | 52 Week Low 0.58
 
NASDAQ USA Most Active Stocks
AMD 96.28 -6.04%
AAPL 140.82 -5.64%
BRQS 0.19 11.76%
SNDL 0.41 -6.82%
GNUS 0.78 13.04%
AGRI 2.92 8.96%
BBIG 3.05 6.64%
ENDP 0.62 -46.55%
NVDA 169.38 -6.82%
SOFI 7.23 2.55%
 
NASDAQ USA Top Gainers Stocks
NDRAW 0.03 200.00%
EYESW 0.48 92.00%
SMIHW 0.15 87.50%
ZJZZT 38.00 78.82%
THCAW 0.33 73.68%
WKSPW 0.63 57.50%
TMPMW 0.11 57.14%
BROGW 0.42 55.56%
PPHPR 0.14 55.56%
EFTRW 0.23 53.33%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
VENAW 0.05 -50.00%
ALACW 0.01 -50.00%
BTAQW 0.01 -50.00%
ENDP 0.62 -46.55%
MDGSW 0.21 -44.74%
ALACR 0.04 -42.86%
IKNX 19.52 -42.42%
NLITW 0.09 -40.00%
ROVRW 1.30 -34.34%
 
 
ARDX
Daily Charts
ARDX
Intraday Charts
Whats New @
Bazaartrend
ARDX
Free Analysis
 
ARDX Important Levels Intraday
RESISTANCE0.70
RESISTANCE0.69
RESISTANCE0.68
RESISTANCE0.67
SUPPORT0.65
SUPPORT0.64
SUPPORT0.63
SUPPORT0.62
 
ARDX Target for Month May
4th UP TARGET3.63
3rd UP TARGET2.68
2nd UP TARGET2.09
1st UP TARGET1.5
1st DOWN TARGET-0.18
2nd DOWN TARGET-0.77
3rd DOWN TARGET-1.36
4th DOWN TARGET-2.31
 
ARDX Weekly Target
4th UP TARGET3.70
3rd UP TARGET2.73
2nd UP TARGET2.12
1st UP TARGET1.52
1st DOWN TARGET-0.20
2nd DOWN TARGET-0.80
3rd DOWN TARGET-1.41
4th DOWN TARGET-2.38
 
ARDX Target for Year 2022
4th UP TARGET17.33
3rd UP TARGET11.98
2nd UP TARGET8.68
1st UP TARGET5.37
1st DOWN TARGET-4.05
2nd DOWN TARGET-7.36
3rd DOWN TARGET-10.66
4th DOWN TARGET-16.01
 
 
ARDX Other Details
Segment EQ
Market Capital 124773992.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ARDX Address
ARDX
 
ARDX Latest News
 
Your Comments and Response on Ardelyx Inc
 
ARDX Business Profile
Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program that is in Phase 2 clinical trial for the treatment of patients with hyperkalemia; and RDX020, a small molecule program for the treatment of metabolic acidosis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Fremont, California. Address: 34175 Ardenwood Boulevard, Fremont, CA, United States, 94555
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service